Menu

Speak directly and say only what you mean. Be loyal to the things you say you are going to do. Keep your promises.

Dudnyk Named a Best Place to Work

For the second year in a row, The Philadelphia Business Journal and Quantum Workplace have named Dudnyk a Best Place to Work.

Dudnyk Earns Multiple MM&M Award Nominations

Dudnyk earned five coveted spots on the Medical Marketing & Media (MM&M) Short List, including, for the third year in a row, Healthcare Agency of the Year.

Digital Dream Projects

PM360 asked marketers to share their digital dream projects. Drew Desjardins wants to see AR-aided rare disease diagnosis.

Client-Agency Relationships 101

Strong relationships require an investment of time, energy, and meaningful engagements. Annemarie Armstrong talks about the key to balancing client-agency relationships in PharmaVOICE.

How to succeed in a rapid-paced, ever-changing industry: my belief and advice to younger generations

President Christopher Tobias, PhD, shares the most important lessons he’s learned during his career so far.

Six Campaigns for Orphan Drugs That Use Real Patients as Advocates

In the May issue of MM&M, Dawn Hastings, associate creative director, takes a look at six campaigns for orphan drugs that use real patients as advocates.

MedAd News Annual Agency Issue

The much-anticipated annual agency issue of MedAd News included a terrific feature on Dudnyk.

From Bench to Bedside: Witnessing Firsthand the Power of Science to Transform Lives

When Jahda Hill, PhD, scientific director, left the lab to join Dudnyk, she never anticipated she would eventually work on the launch of the first therapy based on RNA interference—a scientific approach she used throughout her graduate and postdoctoral training.

Achieving authenticity with patients requires getting personal

The first time I met a person with a rare disease, I was young, less experienced, and completely unprepared for how the interaction would shape my perspective and ultimately lay the foundation for a career that would challenge and inspire me.

Dudnyk Named Finalist for Agency of the Year

Med Ad News Announces Nominees for the 29th Annual Manny Awards

Dudnyk featured among PM360 Greatest Creators

In the Greatest Creator issue, PM360 showcases some of the best creative work from agencies serving the life sciences industry from the past year.

The Value of Online Support Groups in Rare Disease Communities

The existence of online support groups is changing the way people deal with rare
diseases. EVP Laurie Bartolomeo shares her insights on the role that pharma
marketers can play.

From industry to agency-what I learned when I made the big leap

In early 2015, I knew it was time for a career change. After starting as a sales analyst, then completing an MBA and working as a product manager at a large pharmaceutical company, I had advanced to vice president of marketing at a smaller firm, and yet I was ready for something new.

A Private Look Inside a Closed Online Rare Disease Community

Online support groups are helping rare disease families cope with the unthinkable. Here are just 3 ways one such group has empowered my family.

Dudnyk Wins Pharma Choice Gold Award from PM360

PM360, a leading trade magazine in the pharmaceutical, biotech, and medical device industries, has awarded Dudnyk the Gold Pharma Choice Award for Professional Print Campaign for Flexion Therapeutics’ Zilretta.

Dudnyk’s “Mantra” campaign for Shire’s Firazyr earns PM360 Pharma Choice Award

The campaign Dudnyk created for Shire’s Firazyr, called “Mantra,” took home the Bronze award for DTC/DTP.

Dudnyk Executives Featured in the MAN Agency Roundtable Issue

Several Dudnyk team members contributed to the latest issue of Med Ad News. Read our thoughts on topics ranging from patient engagement strategies to the Opioid Epidemic to AR/VR in the annual Healthcare Agency Roundtable.

The Innovation of “The Unifying Effect”

Dudnyk's “The Unifying Effect” was named a 2017 Innovative Strategy by PM360. See how we are changing the way physicians and patients in specialty and rare disease communities connect.

Advancements in Molecular Medicine

PharmaVOICE Trends for the Future: Christopher Tobias, PhD, discusses how major ongoing advancements in molecular medicine in clinical trials are delivering results in the form of FDA-approved treatments for diseases that previously meant bleak long–term outcomes for patients.

The Responsibility of Marketing for Rare Diseases

PharmaVOICE Trends for the Future: Laurie Bartolomeo shares insight into the motivations of marketing to patients with rare diseases. The responsibility to patients is heightened in the rare disease space, she explains, and where there is greater need, there is greater reward.